Sentence examples for reduction adjusted from inspiring English sources

Preterm birth rates (2004 05 vs 1990 91) did not decline (adjusted odds ratio 1.00, 95% CI 0.89 1.14), while low birth weight rates showed a non-significant reduction (adjusted odds ratio 0.91, 95% CI 0.81 1.02, P = 0.11) in the adjusted models.

In a negative binomial difference-in-differences model, implementation of the SRTS program in Texas was associated with a 14% reduction (adjusted IRR 0.86, 95% CI 0.75, 0.98) in pedestrian and bicyclist injury risk in school-age children.

1876 probes showed a consistent pattern of improved detection, where at least 75% of the adjusted detection p-values were <0.05 for the post-globin reduction group and at least 75% were >0.05 in the pre-globin reduction group with a statistically significant difference between the distributions of pre- and post-globin reduction adjusted p-values (Table S1).

§For numbers needed to treat, inverse of absolute risk reduction adjusted for clustering by practice.

We calculated numbers needed to treat from the inverse of the absolute risk reduction adjusted for clustering by practice.

Prisons that implemented smoking bans had a 9% reduction (adjusted incidence rate ratio 0.91, 95% confidence interval 0.88 to 0.95) in smoking related deaths.

For men aged 55 64 years, use of filter cigarettes was associated with a reduction in adjusted ORs for SCC, but not for AC, whereas the magnitude of reduction was similar for SCC and AC in men ⩾65 years.

68 Papazian et al randomized 340 patients with ARDS (PaO2/ FiO2 < 150) to a 48-hour infusion of cisatracurium versus placebo and found a significant reduction in adjusted 90-day mortality (RR 0.68 [95% CI 0.48 0.98], P = 0.04) and trend toward a reduction of the crude 90-day mortality (31.6% versus 40.7%; P = 0.08).

The pOx for ex-situ reduction is adjusted by a 4% H2/Ar mixture resulting in a shift of the equilibrium described by Eqs. 4 and 6.

Papazian and colleagues randomized 340 patients with early severe ARDS to receive continuous infusions of cisatracurium besylate or placebo for 48 h and observed a 30% relative reduction in adjusted mortality risk in the cisatracurium-treated group, as well as more ventilator-free days and no increase in the risk of acquired paresis in the intensive care unit (ICU) [5].

The reduction in adjusted ORs related to SCC and AC in filter-exclusive smokers was similar.